Reflectance confocal microscopy (RCM) is a noninvasive technique for in vivo imaging of the skin that allows evaluation of the total lesion area. This case report about a 66-year-old patient with a clinically indistinctive, previously treated erythematous lesion on the frontal part of the face demonstrates the use of RCM to select the proper biopsy location.
Introduction
Squamous cell carcinoma (SCC) is the second most common nonmelanoma skin cancer after basal cell carcinoma (BCC) [1, 2] . Currently, diagnosis of a clinically suspect SCC or BCC is confirmed by histological evaluation of a skin biopsy obtained from the clinically most suspicious part of the lesion. However, a biopsy only represents a small part of the lesion. Especially in large lesions, this might result in a false-negative diagnosis or in missing a more aggressive part of the lesion [3, 4] . Furthermore, clinical evaluation of previously treated and/or large lesions can be difficult, and in such cases, it is hard to determine the most suspect area for a biopsy.
Reflectance confocal microscopy (RCM) is a noninvasive technique for in vivo imaging of the skin that allows evaluation of the total lesion area [5] . It is known that RCM can visualize nonmelanoma skin cancer, melanoma and inflammatory skin diseases [6, 7] . However, to the best of our knowledge, it is not described whether RCM might be used to select the location of a punch biopsy in a large and clinically indistinctive lesion.
Case Presentation
A 66-year-old patient with an erythematous lesion on the frontal part of the face was referred from the Department of Dermatology of the Bernhoven Hospital, Oss, The Netherlands. At this hospital, the lesion was treated with cryotherapy followed by Efudix. Unfortunately, both treatments were ineffective. A punch biopsy after these therapies revealed the presence of a superficial BCC and, therefore, the lesion was treated with photodynamic therapy. However, the lesion persisted and increased in size. The biopsies obtained after photodynamic therapy showed chronic inflammation and no residual tumor tissue. For further management, the patient was referred to the outpatient clinic of the Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. A clinical diagnosis of the erythematous lesion with a size of 2.3 × 2.1 cm was difficult due to the previously performed biopsies and treatments ( fig. 1 ). This made it challenging to determine the most suspect area for a biopsy. Treatment by surgical excision without prior establishment of the diagnosis was unfavorable due to the size and the location of the lesion. Therefore, we used RCM for a noninvasive evaluation of the complete lesion to select the most suspect area for a biopsy.
The major part of the lesion showed RCM features corresponding to normal skin or actinic keratosis. More importantly, one small part showed prominent aberrant features: a disrupted stratum corneum, keratinocyte atypia, spongiosis, increased capillary blood flow, flattening of the dermal epidermal junction, solar elastosis and a nest of atypical cells ( fig. 2) . These features were suspect for either SCC or BCC. A 3-mm punch biopsy was taken from this part of the lesion. Histopathological evaluation of the biopsy showed the presence of a SCC with an invasive growth of 0.9 mm. The lesion was excised and evaluation of the excision specimen showed multifocal actinic keratosis and two small foci displaying SCC with an invasive growth of 0.8 and 0.5 mm.
Conclusion
Although it is known that RCM can be helpful for the diagnosis of nonmelanoma skin cancer, this case demonstrates the practical use of RCM as a tool to select the location for a punch biopsy in a large and clinically indistinctive lesion. In this case, the foci displaying SCC were only a small part of the total lesion area. Without RCM imaging prior to the biopsy, the most aggressive part of the lesion could have been missed. RCM allows evaluation of the total lesion area, which might reduce sample errors and delay in accurate diagnosis and treatment of large or clinically indistinctive lesions.
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